CORRECTION article

Front. Immunol., 26 June 2025

Sec. Alloimmunity and Transplantation

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1633590

Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial

This article is a correction to:

  1. Impact of Post-Transplant Cyclophosphamide with Bendamustine on Immune Reconstitution in Young Patients Undergoing T-Cell Replete Haploidentical Bone Marrow Transplantation: Results from a Phase Ia/Ib Clinical Trial

    1. Read original article
Forrest L. Baker,,Forrest L. Baker1,2,3Jessica StokesJessica Stokes2Megan J. CracchioloMegan J. Cracchiolo2Dan DaviniDan Davini2Richard J. Simpson,,,Richard J. Simpson1,2,3,4Emmanuel Katsanis,,,*Emmanuel Katsanis2,3,4,5*
  • 1School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ, United States
  • 2Department of Pediatrics, University of Arizona, Tucson, AZ, United States
  • 3The University of Arizona Cancer Center, Tucson, AZ, United States
  • 4Department of Immunobiology, University of Arizona, Tucson, AZ, United States
  • 5Banner University Medical Center, Tucson, AZ, United States

A Correction on
Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial

By Baker FL, Stokes J, Cracchiolo MJ, Davini D, Simpson RJ and Katsanis E (2025) Front. Immunol. 16:1568862. doi: 10.3389/fimmu.2025.1568862

In the published article, Supplementary Table 1 was mistakenly not included in the publication. The missing material appears below:

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: bendamustine, cyclophosphamide, hematopoietic cell transplantation, TCR-β sequencing, T-cells, cytomegalovirus

Citation: Baker FL, Stokes J, Cracchiolo MJ, Davini D, Simpson RJ and Katsanis E (2025) Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial. Front. Immunol. 16:1633590. doi: 10.3389/fimmu.2025.1633590

Received: 22 May 2025; Accepted: 09 June 2025;
Published: 26 June 2025.

Edited and reviewed by:

Robert James Hayashi, Washington University in St. Louis, United States

Copyright © 2025 Baker, Stokes, Cracchiolo, Davini, Simpson and Katsanis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Emmanuel Katsanis, ZWthdHNhbmlAYXJpem9uYS5lZHU=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.